Abnormal sensitivity of cannabinoid CB1 receptors in the striatum of mice with experimental amyotrophic lateral sclerosis

References

• Bruijn LI, Miller TM, Cleveland DW. Unravelling the mechanisms involved in motor neuron degeneration in ALS. Annu Rev Neurosci. 2004; 27: 723–49
   PubMed Web of Science ®Google Scholar
• Nirmalananthan N, Greensmith L. Amyotrophic lateral sclerosis: recent advances and future therapies. Curr Opin Neurol. 2005; 18: 712–9
   PubMed Web of Science ®Google Scholar
• Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993; 362: 59–62
   PubMed Web of Science ®Google Scholar
• Shaw CE, Enayat ZE, Chioza BA, Al-Chalabi A, Radunovic A, Powell JF, et al. Mutations in all five exons of SOD1 may cause ALS. Ann Neurol. 1998; 43: 390–4
   PubMed Web of Science ®Google Scholar
• Takahashi H, Snow BJ, Bhatt MH, Peppard R, Eisen A, Calne DB. Evidence for a dopaminergic deficit in sporadic amyotrophic lateral sclerosis on positron emission scanning. Lancet. 1993; 342: 1016–8
   PubMed Web of Science ®Google Scholar
• Desai J, Swash M. Extrapyramidal involvement in amyotrophic lateral sclerosis: backward falls and retropulsion. J Neurol Neurosurg Psychiatry. 1999; 67: 214–6
   PubMed Web of Science ®Google Scholar
• Petrik MS, Wilson JM, Grant SC, Blackband SJ, Tabata RC, Shan X, et al. Magnetic resonance microscopy and immunohistochemistry of the CNS of the mutant SOD murine model of ALS reveals widespread neural deficits. Neuromolecular Med. 2007; 9: 216–29
   PubMed Web of Science ®Google Scholar
• Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, et al. Motor neuron degeneration in mice that express a human Cu/Zn superoxide dismutase mutation. Science. 1994; 264: 1772–5
   PubMed Web of Science ®Google Scholar
• Pardo CA, Xu Z, Borchelt DR, Price DL, Sisodia SS, Cleveland DW. Superoxide dismutase is an abundant component in cell bodies, dendrites, and axons of motor neurons and in a subset of other neurons. Proc Natl Acad Sci USA. 1995; 92: 954–8
   PubMed Web of Science ®Google Scholar
• Siemiatkowski M, Rokicki D, Członkowska AI, Sienkiewicz-Jarosz H, Bidzi(ski A, Płaźnik A. Locomotor activity and a conditioned fear response: correlation with cortical and subcortical binding of the dopamine D1 receptor antagonist. Neuroreport. 2000; 11: 3953–6
   PubMed Web of Science ®Google Scholar
• Geracitano R, Paolucci E, Prisco S, Guatteo E, Zona C, Longone P, et al. Altered long-term corticostriatal synaptic plasticity in transgenic mice overexpressing human Cu/Zn superoxide dismutase (GLY(93)-- > ALA) mutation. Neuroscience. 2003; 118: 399–408
   PubMed Web of Science ®Google Scholar
• Centonze D, Battista N, Rossi S, Mercuri NB, Finazzi-Agro A, Bernardi G, et al. A critical interaction between dopamine D2 receptors and endocannabinoids mediates the effects of cocaine on striatal GABAergic transmission. Neuropsychopharmacology. 2004; 29: 1488–97
   PubMed Web of Science ®Google Scholar
• Pan B, Hillard CJ, Liu QS. D2 dopamine receptor activation facilitates endocannabinoid-mediated long-term synaptic depression of GABAergic synaptic transmission in midbrain dopamine neurons via cAMP-protein kinase A signalling. J Neurosci. 2008; 28: 14018–30
   PubMed Web of Science ®Google Scholar
• Piomelli D. The molecular logic of endocannabinoid signalling. Nat Rev Neurosci. 2003; 4: 873–84
   PubMed Web of Science ®Google Scholar
• Raman C, McAllister SD, Rizvi G, Patel SG, Moore DH, Abood ME. Amyotrophic lateral sclerosis: delayed disease progression in mice by treatment with a cannabinoid. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004; 5: 33–9
   PubMed Web of Science ®Google Scholar
• Witting A, Weydt P, Hong S, Kliot M, Moller T, Stella N. Endocannabinoids accumulate in spinal cord of SOD1-G93A transgenic mice. J Neurochem. 2004; 89: 1555–7
   PubMed Web of Science ®Google Scholar
• Weydt P, Hong S, Witting A, Möller T, Stella N, Kliot M. Cannabinol delays symptom onset in SOD1-G93A transgenic mice without affecting survival. Amyotroph Lateral Scler Other Motor Neuron Disord. 2005; 6: 182–4
   PubMed Web of Science ®Google Scholar
• Bilsland LG, Dick JR, Pryce G, Petrosino S, Di Marzo V, Baker D, et al. Increasing cannabinoid levels by pharmacological and genetic manipulation delay disease progression in SOD1 mice. FASEB J. 2006; 20: 1003–5
   PubMed Web of Science ®Google Scholar
• Shoemaker JL, Seely KA, Reed RL, Crow JP, Prather PL. The CB2 cannabinoid agonist AM-1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset. J Neurochem. 2007; 101: 87–98
   PubMed Web of Science ®Google Scholar
• Zhao P, Ignacio S, Beattie EC, Abood ME. Altered presymptomatic AMPA and cannabinoid receptor trafficking in motor neurons of ALS model mice: implications for excitotoxicity. Eur J Neurosci. 2008; 27: 572–9
   PubMed Web of Science ®Google Scholar
• Rothstein JD, van Kammen M, Levey AI, Martin LJ, Kuncl RW. Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann Neurol. 1995; 38: 73–84
   PubMed Web of Science ®Google Scholar
• Roy J, Minotti S, Dong L, Figlewicz DA, Durham HD. Glutamate potentiates the toxicity of mutant Cu/Zn superoxide dismutase in motor neurons by postsynaptic calcium-dependent mechanisms. J Neurosci. 1998; 18: 9673–84
   PubMed Web of Science ®Google Scholar
• van den Bosch L, van den Berghe W, Klaassen H, van Houtte E, Robberecht W. Ca(2+)-permeable AMPA receptors and selective vulnerability of motor neurons. J Neurol Sci. 2000; 180: 29–34
   PubMed Web of Science ®Google Scholar
• Pieri M, Gaetti C, Spalloni A, Cavalcanti S, Mercuri N, Bernardi G, et al. Alpha-amino-3-hydroxy-5-methyl-isoxazole-4-propionate receptors in spinal cord motor neurons are altered in transgenic mice overexpressing human Cu/Zn superoxide dismutase (Gly93-- > Ala) mutation. Neuroscience. 2003; 122: 47–58
   PubMed Web of Science ®Google Scholar
• Kawahara Y, Kwak S. Excitotoxicity and ALS: what is unique about the AMPA receptors expressed on spinal motor neurons?. Amyotroph Lateral Scler Other Motor Neuron Disord. 2005; 6: 131–44
   PubMed Web of Science ®Google Scholar
• Tortarolo M, Grignaschi G, Calvaresi N, Zennaro E, Spaltro G, Colovic M, et al. Glutamate AMPA receptors change in motor neurons of SOD1-G93A transgenic mice and their inhibition by a non-competitive antagonist ameliorates the progression of amyotrophic lateral sclerosis-like disease. J Neurosci Res. 2006; 83: 134–46
   PubMed Web of Science ®Google Scholar
• Centonze D, Rossi S, Prosperetti C, Tscherter A, Bernardi G, Maccarrone M, et al. Abnormal sensitivity to cannabinoid receptor stimulation might contribute to altered gamma-aminobutyric acid transmission in the striatum of R6/2 Huntington's disease mice. Biol Psychiatry. 2005; 57: 1583–9
   PubMed Web of Science ®Google Scholar
• Centonze D, Bari M, Rossi S, Prosperetti C, Furlan R, Fezza F, et al. The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis. Brain. 2007; 130: 2543–53
   PubMed Web of Science ®Google Scholar
• Centonze D, Rossi S, de Chiara V, Prosperetti C, Battista N, Bernardi G, et al. Chronic cocaine sensitizes striatal GABAergic synapses to the stimulation of cannabinoid CB1 receptors. Eur J Neurosci. 2007; 25: 1631–40
   PubMed Web of Science ®Google Scholar
• Rossi S, de Chiara V, Musella A, Kusayanagi H, Mataluni G, Bernardi G, et al. Chronic psychoemotional stress impairs cannabinoid-receptor-mediated control of GABA transmission in the striatum. J Neurosci. 2008; 28: 7284–92
   PubMed Web of Science ®Google Scholar
• Szabo B, Urbanski MJ, Bisogno T, Di Marzo V, Mendiguren A, Baer WU, et al. Depolarization-induced retrograde synaptic inhibition in the mouse cerebellar cortex is mediated by 2-arachidonoylglycerol. J Physiol. 2006; 577: 263–80
   PubMed Web of Science ®Google Scholar
• Gerdeman G, Lovinger DM. CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum. J Neurophysiol. 2001; 85: 468–71
   PubMed Web of Science ®Google Scholar
• Andersson M, Usiello A, Borgkvist A, Pozzi L, Dominguez C, Fienberg AA, et al. Cannabinoid action depends on phosphorylation of dopamine- and cAMP-regulated phosphoprotein of 32 kDa at the protein kinase A site in striatal projection neurons. J Neurosci. 2005; 25: 8432–8
   PubMed Web of Science ®Google Scholar
• Ade KK, Lovinger DM. Anandamide regulates postnatal development of long-term synaptic plasticity in the rat dorsolateral striatum. J Neurosci. 2007; 27: 2403–9
   PubMed Web of Science ®Google Scholar
• Cozzolino M, Amori I, Pesaresi MG, Ferri A, Nencini M, Carrì MT. Cysteine 111 affects aggregation and cytotoxicity of mutant Cu/Zn superoxide dismutase associated with familial amyotrophic lateral sclerosis. J Biol Chem. 2008; 283: 866–74
   PubMed Web of Science ®Google Scholar
• Zhang B, Tu P, Abtahian F, Trojanowski JQ, Lee VM. Neurofilaments and orthograde transport are reduced in ventral root axons of transgenic mice that express human SOD1 with a G93A mutation. J Cell Biol. 1997; 139: 1307–15
   PubMed Web of Science ®Google Scholar
• Williamson TL, Cleveland DW. Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons. Nat Neurosci. 1999; 2: 50–6
   PubMed Web of Science ®Google Scholar
• Gubellini P, Picconi B, Bari M, Battista N, Calabresi P, Centonze D, et al. Experimental Parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission. J Neurosci. 2002; 22: 6900–7
   PubMed Web of Science ®Google Scholar
• Hansen HH, Azcoitia I, Pons S, Romero J, García-Segura LM, Ramos JA, et al. Blockade of cannabinoid CB(1) receptor function protects against in vivo disseminating brain damage following NMDA-induced excitotoxicity. J Neurochem. 2002; 82: 154–8
   PubMed Web of Science ®Google Scholar
• Hansen HH, Krutz B, Sifringer M, Stefovska V, Bittigau P, Pragst F, et al. Cannabinoids enhance susceptibility of immature brain to ethanol neurotoxicity. Ann Neurol. 2008; 64: 42–52
   PubMed Web of Science ®Google Scholar
• Downer EJ, Fogarty MP, Campbell VA. Tetrahydrocannabinol-induced neurotoxicity depends on CB1 receptor-mediated c-Jun N-terminal kinase activation in cultured cortical neurons. Br J Pharmacol. 2003; 140: 547–57
   PubMed Web of Science ®Google Scholar
• Downer EJ, Gowran A, Murphy AC, Campbell VA. The tumour suppressor protein, p53, is involved in the activation of the apoptotic cascade by Delta9-tetrahydrocannabinol in cultured cortical neurons. Eur J Pharmacol. 2007; 564: 57–65
   PubMed Web of Science ®Google Scholar
• Shen M, Thayer SA. Cannabinoid receptor agonists protect cultured rat hippocampal neurons from excitotoxicity. Mol Pharmacol. 1998; 54: 459–62
   PubMed Web of Science ®Google Scholar
• Marsicano G, Goodenough S, Monory K, Hermann H, Eder M, Cannich A, et al. CB1 cannabinoid receptors and on-demand defence against excitotoxicity. Science. 2003; 302: 84–8
   PubMed Web of Science ®Google Scholar
• Pryce G, Ahmed Z, Hankey DJ, Jackson SJ, Croxford JL, Pocock JM, et al. Cannabinoids inhibit neurodegeneration in models of multiple sclerosis. Brain. 2003; 126: 2191–202
   PubMed Web of Science ®Google Scholar
• Gilbert GL, Kim HJ, Waataja JJ, Thayer SA. Delta9-tetrahydrocannabinol protects hippocampal neurons from excitotoxicity. Brain Res. 2007; 1128: 61–9
   PubMed Web of Science ®Google Scholar
• Nagayama T, Sinor AD, Simon RP, Chen J, Graham SH, Jin K, et al. Cannabinoids and neuroprotection in global and focal cerebral ischaemia and in neuronal cultures. J Neurosci. 1999; 19: 2987–95
   PubMed Web of Science ®Google Scholar
• van der Stelt M, Veldhuis WB, van Haaften GW, Fezza F, Bisogno T, Bar PR, et al. Exogenous anandamide protects rat brain against acute neuronal injury in vivo. J Neurosci. 2001; 21: 8765–71
   PubMed Web of Science ®Google Scholar
• Facchinetti F, del Giudice E, Furegato S, Passarotto M, Leon A. Cannabinoids ablate release of TNFalpha in rat microglial cells stimulated with lypopolysaccharide. Glia. 2003; 41: 161–8
   PubMed Web of Science ®Google Scholar
• Puffenbarger RA, Boothe AC, Cabral GA. Cannabinoids inhibit LPS-inducible cytokine mRNA expression in rat microglial cells. Glia. 2000; 29: 58–69
   PubMed Web of Science ®Google Scholar
• McGeer PL, McGeer EG. Inflammatory processes in amyotrophic lateral sclerosis. Muscle Nerve. 2002; 26: 459–70
   PubMed Web of Science ®Google Scholar
• Liang X, Wang Q, Shi J, Lokteva L, Breyer RM, Montine TJ, et al. The prostaglandin E2 EP2 receptor accelerates disease progression and inflammation in a model of amyotrophic lateral sclerosis. Ann Neurol. 2008; 64: 304–14
   PubMed Web of Science ®Google Scholar
• Boillée S, van de Velde C, Cleveland DW. ALS: a disease of motor neurons and their non-neuronal neighbours. Neuron. 2006; 52: 39–59
   PubMed Web of Science ®Google Scholar